Product Liability 2009 - Arnold & Porter LLP
Product Liability 2009 - Arnold & Porter LLP
Product Liability 2009 - Arnold & Porter LLP
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Chapter 34<br />
Norway<br />
Advokatfirmaet Wiersholm, Mellbye & Bech AS<br />
1 <strong>Liability</strong> Systems<br />
1.1 What systems of product liability are available (i.e. liability<br />
in respect of damage to persons or property resulting from<br />
the supply of products found to be defective or faulty)? Is<br />
liability fault based, or strict, or both? Does contractual<br />
liability play any role? Can liability be imposed for breach<br />
of statutory obligations e.g. consumer fraud statutes?<br />
<strong>Product</strong> liability can be based both on negligence, a customary<br />
norm derived from judicial decisions and legal theory, and strict<br />
liability under the <strong>Product</strong> <strong>Liability</strong> Act, “PLA”, (104/1988). This<br />
article will deal mainly with the rules in the PLA.<br />
Furthermore, product liability can rest on a breach of contract. If a<br />
product is defective and does not possess the contractually<br />
promised properties, it may lead to strict or fault-based liability<br />
under the Purchase Act (27/1988).<br />
A claimant may choose between these three systems. Neither legal<br />
basis precludes the use of another, but the different systems may not<br />
cover all kinds of damages. In some instances, the claimant must<br />
establish that the “manufacturer” acted negligently, cf. PLA section<br />
1-3 (1).<br />
1.2 Does the state operate any schemes of compensation for<br />
particular products?<br />
Yes. In accordance with the Protection from Infection Act<br />
(55/1994), the Government may be obliged to pay standardised<br />
damages caused by vaccinations. Compensation for damages<br />
caused to patients during medical treatment in the public health care<br />
system is regulated in the Patient Injury Act (53/2001). Under the<br />
same act private health care institutions must provide insurance for<br />
claims related to medical treatment. Compensation for damages<br />
caused by vehicles is established in the <strong>Liability</strong> for Vehicles Act<br />
(1/1961). In Chapter 3, the PLA lays down a separate compensation<br />
scheme for damages caused by the use of and the testing of<br />
medicines.<br />
1.3 Who bears responsibility for the fault/defect? The<br />
manufacturer, the importer, the distributor, the “retail”<br />
supplier or all of these?<br />
The PLA sets out that nearly everyone in the chain of distribution<br />
may be held responsible, including the manufacturer, the importer,<br />
and the supplier of the product, cf. the PLA section 1-3 (1).<br />
ICLG TO: PRODUCT LIABILITY <strong>2009</strong><br />
© Published and reproduced with kind permission by Global Legal Group Ltd, London<br />
1.4 In what circumstances is there an obligation to recall<br />
products, and in what way may a claim for failure to recall<br />
be brought?<br />
Under the <strong>Product</strong> Control Act (79/1976) section 6a, there is an<br />
obligation to recall products if they constitute “an unacceptable<br />
risk” of causing damage to people’s health or the natural<br />
environment, and the government issues a binding order of product<br />
recall. A failure to comply with this order may result in a fine. In<br />
addition, the government may request a court to issue a compliance<br />
order in the event of the “manufacturer” is in non-compliance, or<br />
choose to permanently uphold the order in the court system.<br />
1.5 Do criminal sanctions apply to the supply of defective<br />
products?<br />
A negligent or intentional violation of the <strong>Product</strong> Control Act<br />
(79/1976) section 6a is sanctioned with a fine or imprisonment for<br />
up to 3 months, or both. In cases of gross negligence, the Penal<br />
Code (10/1902) applies.<br />
2 Causation<br />
Magnus Hellesylt<br />
Nicolai Nyland<br />
2.1 Who has the burden of proving fault/defect and damage?<br />
As a general rule the claimant has the burden of proof and must<br />
establish the factual basis for his claim under all three systems of<br />
liability: the PLA, fault-based liability, or contractually based<br />
liability in accordance with the Purchase Act, (27/1988).<br />
If a claimant submits evidence that the court considers prima facie<br />
proof of a fact relating to any of the conditions for liability, this<br />
creates an evidentiary burden upon the opposing party. He must<br />
present evidence to refute the presumption. In relation to claims<br />
based on the PLA, the “manufacturer” must refute, cf. section 1-3 (1).<br />
Norwegian courts are free to weigh the evidence in the particular<br />
case as they see fit.<br />
2.2 What test is applied for proof of causation? Is it enough<br />
for the claimant to show that the defendant wrongly<br />
exposed the claimant to an increased risk of a type of<br />
injury known to be associated with the product, even if it<br />
cannot be proved by the claimant that the injury would<br />
not have arisen without such exposure?<br />
Under the PLA section 2-1, the manufacturer is obliged to<br />
compensate for damages caused by the product having a “safety<br />
deficiency”. A “safety deficiency” exists when the product does not<br />
WWW.ICLG.CO.UK<br />
247